A pharmaceutically acceptable salt of sulfonyl compound which selectively modulate the cb2 receptor.
PK201100616A0Undetermined Publication Date: 2011-09-14BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100616
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-08-24
- Publication Date
- 2011-09-14
Need to check novelty before this filing date? Find Prior Art
No text content released.